-
Mashup Score: 10Regional variations in heart failure: a global perspective - 6 day(s) ago
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in risk factors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region. Recent research has provided insight into many of these disparities, but there remain large gaps in our understanding of worldwide variations in HF care. Although the majority of the global population resides across Asia, Africa and South America, these regions remain poorly represented in epidemiological studies and HF trials. Recent efforts and registries have provided insight into the clinical profiles and outcomes across HF patterns globally. The prevalence of HF and associated risk factors has been reported and varies by country and region ranges, with minimal data on regional variations in treatment patterns and long-term outcomes. It is critical to im
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 146
Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
🔺There is no high-quality evidence to support use of #BetaBlockers in #HFpEF https://t.co/jYfTPnGUiR 🔺In absence of other indications, consider withdrawing BBs from HFpEF regimen, especially in setting of #chronotropic incompetence (ie chronotropic index <0.62 during max #CPET) https://t.co/U1wYvLR1tF https://t.co/3PUWqpKh2F
-
-
Mashup Score: 141
Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
🔺There is no high-quality evidence to support use of #BetaBlockers in #HFpEF https://t.co/jYfTPnGUiR 🔺In absence of other indications, consider withdrawing BBs from HFpEF regimen, especially in setting of #chronotropic incompetence (ie chronotropic index <0.62 during max #CPET) https://t.co/U1wYvLR1tF https://t.co/3PUWqpKh2F
-
-
Mashup Score: 10Regional variations in heart failure: a global perspective - 1 month(s) ago
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in risk factors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region. Recent research has provided insight into many of these disparities, but there remain large gaps in our understanding of worldwide variations in HF care. Although the majority of the global population resides across Asia, Africa and South America, these regions remain poorly represented in epidemiological studies and HF trials. Recent efforts and registries have provided insight into the clinical profiles and outcomes across HF patterns globally. The prevalence of HF and associated risk factors has been reported and varies by country and region ranges, with minimal data on regional variations in treatment patterns and long-term outcomes. It is critical to im
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Regional variations in heart failure: a global perspective - 1 month(s) ago
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in risk factors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region. Recent research has provided insight into many of these disparities, but there remain large gaps in our understanding of worldwide variations in HF care. Although the majority of the global population resides across Asia, Africa and South America, these regions remain poorly represented in epidemiological studies and HF trials. Recent efforts and registries have provided insight into the clinical profiles and outcomes across HF patterns globally. The prevalence of HF and associated risk factors has been reported and varies by country and region ranges, with minimal data on regional variations in treatment patterns and long-term outcomes. It is critical to im
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 10Regional variations in heart failure: a global perspective - 1 month(s) ago
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in risk factors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region. Recent research has provided insight into many of these disparities, but there remain large gaps in our understanding of worldwide variations in HF care. Although the majority of the global population resides across Asia, Africa and South America, these regions remain poorly represented in epidemiological studies and HF trials. Recent efforts and registries have provided insight into the clinical profiles and outcomes across HF patterns globally. The prevalence of HF and associated risk factors has been reported and varies by country and region ranges, with minimal data on regional variations in treatment patterns and long-term outcomes. It is critical to im
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 22In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo | Annals of Internal Medicine - 2 month(s) ago
Source Citation Maurer MS, Kale P, Fontana M, et al; APOLLO-B Trial Investigators. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med. 2023;389:1553-1565. 37888916
Source: www.acpjournals.orgCategories: General Medicine News, CardiologistsTweet-
Appraisal of #ApolloB #RCT for #ACPJournalClub w @MasriAhmadMD @AnnalsofIM In RCT of 360 ppl w #ATTR cardiac #amyloidosis, those on #patisiran experienced modest improvem’t in #6MWT Unclear benefit in those on tafamidis 🔗 https://t.co/9MEPU6AYsx 🔗 https://t.co/a45tThktTd https://t.co/wmfB1okPxv
-
-
Mashup Score: 3Bill Evans - Never Let Me Go - 2 month(s) ago
Evans’s Universal MindAlone. 1968
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19Oasis - Wonderwall (Official Video) - 2 month(s) ago
Oasis – ‘Wonderwall’ (Official Video)Taken from the album ‘(What’s The Story) Morning Glory?’Directed by: Nigel DickSUBSCRIBE ▶︎ https://Oasis.lnk.to/YTSubsc…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
Spring equinox and it’s -14°C with the wind chill and I need to move someplace warmer! But 🎶 & laughs with our #Echo fellows adds warmth to this Echo lab day “And all the roads we have to walk are winding”.. so true! What are you listening to? https://t.co/HNIsGgQe5c https://t.co/YeMg5JqtRX
-
-
Mashup Score: 10Regional variations in heart failure: a global perspective - 2 month(s) ago
Heart failure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in risk factors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region. Recent research has provided insight into many of these disparities, but there remain large gaps in our understanding of worldwide variations in HF care. Although the majority of the global population resides across Asia, Africa and South America, these regions remain poorly represented in epidemiological studies and HF trials. Recent efforts and registries have provided insight into the clinical profiles and outcomes across HF patterns globally. The prevalence of HF and associated risk factors has been reported and varies by country and region ranges, with minimal data on regional variations in treatment patterns and long-term outcomes. It is critical to im
Source: heart.bmj.comCategories: General Medicine News, CardiologistsTweet
RT @Heart_BMJ: Regional variations in heart failure: a global perspective https://t.co/NjOejjoHBN🌎 🗺️ https://t.co/oSBI6KqwAR